Target intelligence / Profile preview

MROH7-TTC4 readthrough RNA (NMD candidate) (MROH7-TTC4)

Target
MROH7-TTC4
Molecular classification
Other (long non-coding RNA—readthrough transcript)
01

Overview

MROH7-TTC4 readthrough is a non-coding RNA gene resulting from a natural transcriptional readthrough event between the MROH7 and TTC4 loci on chromosome 1. This RNA is subject to alternative splicing, producing several transcript variants that are generally candidates for nonsense-mediated mRNA decay and are therefore unlikely to encode for a protein[1][2]. Functional annotation is limited, with minimal evidence for a direct biological role. The locus has been referenced in research examining vascular endothelial cell autophagy: specifically, regulation of its expression by upstream proteins (such as annexin A7) may indirectly influence processes like apoptosis in vascular endothelial cells, but its own mechanistic contribution remains unclear[3]. Currently, MROH7-TTC4 is not considered a druggable therapeutic target, a receptor, enzyme, or member of classical protein families. No disease associations, biomarkers, or drug interactions are reported.

Other names
C1orf175HEATR8HEATR8-TTC4Maestro heat-like repeat-containing protein family member 7MROH7HEATR8-TTC4 readthroughMROH7-TTC4 readthrough
02

Biological functions

Other (no established protein-encoded function; "binding" is the only reported Gene Ontology function, likely reflecting sequence characteristics rather than an active biological role)
03

Disease associations

Other (no direct disease association; however, its expression is referenced as being regulated in endothelial cell studies related to autophagy and apoptosis, but no direct disease link for the RNA itself)

Beyond the preview

Go deeper on MROH7-TTC4 readthrough RNA (NMD candidate) (MROH7-TTC4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MROH7-TTC4 readthrough RNA (NMD candidate) (MROH7-TTC4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call